FDA approves drug to treat sickle cell disease in patients aged 4 up to 11 years
NEWS & BLOGS
FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease
FDA Approves First Drug to Prevent Graft Versus Host Disease
FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds
FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19
FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention
FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions
FDA Approves First Treatment for Post- Transplant Infection that is Resistant to Other Drugs
FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism
FDA Expands Eligibility for COVID-19 Vaccine Boosters
FDA Provides New Draft Guidance on Premarket Submissions for Device Software Functions
FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years
FDA Continues Efforts to Detect and Assess Asbestos in Cosmetics for Consumers
FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
FDA Issues Landmark Proposal to Improve Access to Hearing Aid Technology
FDA approves add-on drug for adults with rare form of blood vessel inflammation
FDA authorizes new over-the-counter home COVID-19 test
FDA approves add-on drug for ages 10 & up with rare forms of high cholesterol
FDA updates on sunscreen requirements